BridgeBio Pharma Inc (BBIO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

featured-image

BridgeBio Pharma Inc (BBIO) reports robust financial performance and strategic advancements, driven by the successful launch of Attruby and a strong cash position.

BridgeBio Pharma Inc (BBIO) reports robust financial performance and strategic advancements, driven by the successful launch of Attruby and a strong cash position..